SPERO BIOPHARMA
Spero Biopharma is developing Ladostigil an innovative treatment for Mild Cognitive Impairment. Spero Biopharma was founded by Prof. Marta Weinstock-Rosin, a world-renowned researcher of Alzheimer's disease. Prof. Weinstock-Rosin is the inventor of Exelon®, a blockbuster drug for the treatment of Alzheimer’s disease, and a professor emeritus at the Hebrew University’s School of Pharmacy-Institute for Drug Research in the Faculty of Medicine.
SPERO BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Wellness
Founded:
2019-06-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.sperobio.com
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Content Delivery Network SSL By Default HSTS Google Google Cloud Google Apps For Business Sectigo SSL
Similar Organizations
CannaPowder
CannaPowder is a bio-pharma company dedicated to developing and applying innovative technology.
Etern
Etern is a biopharma company.
NanoPaz Pharma
NanoPaz Pharma specializes in research, development, and testing of an innovative treatment and products for advancing women’s health.
Sebana Medical
Sebana Medical is a biopharmaceutical company that develops a new type of dermal filler.
Current Employees Featured
Founder
Official Site Inspections
http://www.sperobio.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Spero Biopharma"
Home | Spero Biopharma
Spero Biopharma Ltd. was founded by Prof. Marta Weinstock-Rosin, a world-renowned inventor and researcher who invented Exelon®, a blockbuster drug for the treatment of Alzheimer’s …See details»
Spero Biopharma - Crunchbase Company Profile & Funding
Spero Biopharma is developing Ladostigil an innovative treatment for Mild Cognitive Impairment. Spero Biopharma was founded by Prof. Marta Weinstock-Rosin, a world-renowned researcher …See details»
Spero Biopharma - 2025 Company Profile & Competitors - Tracxn
Apr 5, 2025 Spero Biopharma is an unfunded company based in Jerusalem (Israel), founded in 2019 by Marta Rosin Weinstock. It operates as a Developer of treatment therapy for the …See details»
Spero
W e’ve solved the key roadblocks to the industrial use of cell-free metabolic engineering. We're hitting the ground running with a reaction comprising nearly 70 enzymes. Why cell-free? …See details»
Spero Biopharma - Israeli Startup | Startup Nation Finder
Your organization type * -- select an option -- Startup Investor Hub (accelerator, community or similar) Corporation Job seeker Consultant or service provider SME (Small and medium-sized …See details»
About Us | Spero Science-Innovation
Spero is a Health and Biotech company that has in its DNA the rigor of the scientific methodology for the development of its projects. We have a highly qualified and powerful team, with complementary skills and group work …See details»
Spero Oncology - Crunchbase Company Profile
Spero Oncology has joined Veristat, a US-based full service CRO with over 20 years of experience supporting pharmaceutical, biotechnology and medical device firms throughout the clinical trials and regulatory process, primarily in …See details»
About Us | Spero Therapeutics
Our team is fueled by a passion for the communities we serve and guided by the profound meaning of the Latin word “spero,” which encapsulates our vision: to bring hope to patients and caregivers alike who are grappling with the …See details»
Spero Therapeutics - Operations Team - The Org
The Operations Team at Spero Therapeutics is responsible for ensuring the seamless execution of the company's strategic initiatives and daily operational activities.See details»
Spero Therapeutics - Crunchbase Company Profile
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high …See details»
Spero Therapeutics names Esther Rajavelu as Interim President …
Jan 10, 2025 Esther Rajavelu named Interim President & CEO of Spero Therapeutics amid leadership changes due to SEC disclosures.See details»
Spero Therapeutics Provides Business Update and Announces
Jan 10, 2025 CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and …See details»
Spero Biopharma - Overview, News & Similar companies - ZoomInfo
View Spero Biopharma (www.sperobio.com) location in Tel Aviv, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Meet Spero, a biotech hopeful with Roche's blessing and a novel ...
Apr 9, 2014 With seed funding from Atlas Venture and an early-stage partnership with Roche, startup Spero Therapeutics is striking out with a novel approach to drug-resistant bacteria …See details»
Spero Therapeutics - The Pharmaletter
The US company's lead product candidate, tebipenem HBr (tebipenem pivoxil hydrobromide; formerly SPR994), is being developed as the first oral carbapenem antibiotic for use in …See details»
CIAO Study: A long and ongoing look at the secrets of human …
May 5, 2025 For credentialed journalists seeking to attend the symposium, please contact Valeria Albini at Great Health Science with name, news organization and contact information. …See details»
Spero Therapeutics (SPRO) Company Profile & Description - Stock …
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare …See details»
Spero Therapeutics - Craft
Spero Therapeutics has 3 employees at their 1 location and $103.78 m in annual revenue in FY 2023. See insights on Spero Therapeutics including office locations, competitors, revenue, …See details»
Spero Therapeutics | New Therapies For Patients With Rare Diseases
Spero Therapeutics is dedicated to delivering differentiated medicines to help patients suffering from rare diseases and multidrug-resistant (MDR) bacterial infections.See details»
Spero Therapeutics, Inc. (SPRO): history, ownership, mission, how it ...
Ever wondered about the journey of a biopharmaceutical company dedicated to tackling rare diseases and multi-drug resistant bacterial infections? This blog post dives into Spero …See details»